You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Testis Specific Isozyme LDH-C4 Activities in Rat Plasma and Testis Following Acute Exposure to 1,3-DNB and EGME: A Novel Marker of Testicular Damage

Human & Experimental Toxicology

Impact Factor: 3.2 / 5-Year Impact Factor: 3.0

Journal Homepage Submission guidelines

Restricted access

Other

First published online March, 1988

Testis Specific Isozyme LDH-C4 Activities in Rat Plasma and Testis Following Acute Exposure to 1,3-DNB and EGME: A Novel Marker of Testicular Damage

, , and

Volume 7, Issue 2

https://doi.org/10.1177/096032718800700241

Abstract

Get full access to this article

View all access options for this article.

References

Itoh R. & Ozasa H. Changes in serum lactate dehydrogenase isozyme-X activity observed after cadmium administration. Toxicology Letters 1985; 28: 151-4.

Browse journal

All articles Browse by year

Similar articles

Retricted access

Pharmacological evaluation of methanolic leaf extract of Swietenia mahagoni on acrylamide-induced neuropathic pain in rats

Retricted access

Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate

Retricted access

Metoprolol and diltiazem ameliorate ziprasidone-induced prolonged corrected QT interval in rats

Retricted access

Clinician-trialist rounds: 25. Designing an evidence-based introductory graduate course in clinical trials. Part 2: Applying the evidence to your RCT course design